NCT00237575 Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer Status TERMINATED Phase PHASE3
NCT00235989 Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00230282 Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00226512 To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning Status WITHDRAWN Phase PHASE3
NCT00225199 Efficacy and Safety of SH T00660AA in Treatment of Endometriosis Status COMPLETED Phase PHASE3
NCT00225186 Safety and Efficacy of SH T00660AA in Treatment of Endometriosis Status COMPLETED Phase PHASE3
NCT00220324 Pearl Index Study With Low Dose Combined Oral Contraceptive Status COMPLETED Phase PHASE3
NCT00220298 Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism Status COMPLETED Phase PHASE3
NCT00220285 Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00219908 Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis Status TERMINATED Phase PHASE2
NCT00216931 Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost Status WITHDRAWN Phase NA
NCT00214903 European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT) Status COMPLETED Phase N/A
NCT00212485 Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint Disease Status COMPLETED Phase NA
NCT00208975 Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab Status TERMINATED Phase PHASE2
NCT00206648 An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS Status COMPLETED Phase PHASE4
NCT00206635 Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase N/A
NCT00206622 Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes Status COMPLETED Phase PHASE4
NCT00206583 Efficacy and Safety Study of an Oral Contraceptive in Healthy Females Status COMPLETED Phase PHASE3